Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)

About the company

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

8

$2.00M

Total Revenue

8

Employees

$76.80M

Market Capitalization

-3.31

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-19M

Net Margin (in %)

Total net margin

$-19M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 381445.74 82729.00 6.13 22.23 20.75
Merck & Co., Inc. MRK 196786.55 48081.00 7.39 19.42 21.10
Pfizer Inc. PFE 188747.85 50660.00 2.86 11.95 31.17
Eli Lilly & Co. LLY 151075.27 23087.00 51.27 26.63 23.97
AbbVie, Inc. ABBV 145342.96 34057.00 -23.26 17.33 24.65
Bristol Myers Squibb Co. BMY 108491.37 31006.00 2.63 92.24 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4839.72 20.00 22.93 -15.57 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3946.28 1.00 36.49 -6.04 None
Allakos, Inc. ALLK 3152.76 None 6.84 -33.71 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
Karuna Therapeutics, Inc. KRTX 2485.08 None 6.49 -61.27 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
IGM Biosciences, Inc. IGMS 2221.15 None 9.79 -40.94 None
Turning Point Therapeutics, Inc. TPTX 2195.28 None 6.61 -18.37 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2094.84 None 9.25 -5.02 None
Springworks Therapeutics, Inc. SWTX 1695.06 None 5.51 -27.19 None
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1495.17 None 9.16 -16.23 None
Zymeworks, Inc. ZYME 1473.78 26.00 3.06 -8.69 -629.37
Tricida, Inc. TCDA 1300.46 None 6.69 -6.16 None
Akcea Therapeutics, Inc. AKCA 1289.13 341.00 2.65 -45.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1267.20 None 6.56 -10.47 None
Akero Therapeutics, Inc. AKRO 1138.62 None 9.51 -22.44 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Arcutis Biotherapeutics, Inc. ARQT 1074.85 None 4.58 -17.19 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 932.16 None 4.39 -10.04 None
G1 Therapeutics, Inc. GTHX 811.30 1.00 3.51 -6.19 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 750.75 None 4.17 -2.76 None
Quanterix Corp. QTRX 742.50 60.00 6.55 -16.98 -71.52
Krystal Biotech, Inc. KRYS 721.31 None 4.21 -34.78 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Applied Therapeutics, Inc. APLT 686.84 14.00 4.43 -13.94 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 647.22 None 5.73 -19.14 None
Amneal Pharmaceuticals, Inc. AMRX 637.05 1679.00 4.39 -2.92 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 632.06 19.00 58.58 -22.72 -151.34
Keros Therapeutics, Inc. KROS 601.74 8.00 -27.18 -28.33 -285.35
Oyster Point Pharma, Inc. OYST 546.00 None 5.49 -9.49 None
Mirum Pharmaceuticals, Inc. MIRM 491.75 None 3.20 -7.26 None
SIGA Technologies, Inc. SIGA 467.40 19.00 5.23 -23.75 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Fulcrum Therapeutics, Inc. FULC 444.13 1.00 7.48 -6.44 None
Osmotica Pharmaceuticals Plc OSMT 442.80 232.00 3.36 -1.61 -115.44
Biospecifics Technologies Corp. BSTC 442.54 40.00 3.59 18.93 61.80
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 395.33 None 3.82 -11.23 None
DURECT Corp. DRRX 394.04 28.00 30.26 -16.30 -82.94
TCR2 Therapeutics, Inc. TCRR 383.04 None 2.62 -38.00 None
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
Relmada Therapeutics, Inc. RLMD 380.88 0.00 5.68 -31.82 -877.66
Crinetics Pharmaceuticals, Inc. CRNX 376.08 1.00 4.75 -6.45 -447.78
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 349.65 None 8.27 -5.36 None
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 285.60 None -5.06 -1.98 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Gritstone Oncology, Inc. GRTS 255.60 4.00 2.29 -2.45 None
AMAG Pharmaceuticals, Inc. AMAG 240.04 321.00 0.92 -0.65 -115.05
Lannett Co., Inc. LCI 234.84 542.00 0.80 -7.72 -5.77
KalVista Pharmaceuticals, Inc. KALV 224.64 12.00 2.48 -6.93 -263.38
Verrica Pharmaceuticals, Inc. VRCA 219.00 None 4.00 -7.18 None
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Sutro Biopharma, Inc. STRO 200.79 41.00 3.81 -3.29 -148.06
Veru, Inc. VERU 200.20 39.00 6.70 -20.53 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Protara Therapeutics, Inc. TARA 173.10 None 2.60 -11.23 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Lyra Therapeutics, Inc. LYRA 145.68 1.00 -1.24 -8.73 -491.16
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
scPharmaceuticals, Inc. SCPH 143.36 119.00 3.66 -4.57 -27.05
Evelo Biosciences, Inc. EVLO 140.80 None 5.18 -1.61 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
Aquestive Therapeutics, Inc. AQST 123.48 49.00 -7.11 -1.76 -139.64
Harrow Health, Inc. HROW 122.46 51.00 7.85 -4.96 -47.54
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 112.20 3.00 -2.64 -5.44 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Trevi Therapeutics, Inc. TRVI 93.60 None 1.98 -3.19 None
Milestone Pharmaceuticals, Inc. MIST 91.50 None 0.90 -1.47 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 72.57 6.00 9.32 -4.12 -293.61
Xeris Pharmaceuticals, Inc. XERS 72.24 4.00 3.58 -0.56 None
Navidea Biopharmaceuticals, Inc. NAVB 68.17 1.00 -50.13 -6.17 -65.13
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 54.12 20.00 1.63 -2.87 -51.58
Menlo Therapeutics, Inc. MNLO 48.72 2.00 4.10 -0.52 -483.51
Eyenovia, Inc. EYEN 45.12 None 4.55 -2.20 None
Edesa Biotech, Inc. EDSA 44.01 0.00 6.27 -0.46 -395.23
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.48 None 3.52 -4.40 None
Acer Therapeutics, Inc. ACER 36.30 3.00 2.65 -1.39 -274.69
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 34.83 None 2.58 -2.02 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Mannatech, Inc. MTEX 33.40 156.00 1.41 7.52 3.45
Allena Pharmaceuticals, Inc. ALNA 33.35 None 4.39 -0.77 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
CNS Pharmaceuticals, Inc. CNSP 29.28 None 5.08 -5.38 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 19.76 1.00 8.67 -1.18 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.38 5.00 -3.31 -0.46 -602.34
PDS Biotechnology Corp. PDSB 13.93 None 1.54 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 8.01 None 0.69 -0.38 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

CKPT Checkpoint Therapeutics, Inc. Common Stock

8d ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Checkpoint Therapeutics Inc.

21d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Immune Checkpoint Inhibitors Market to Grow at a CAGR of 25.3% During the Forecast Period 2020-2025

4d ago, source: MarketWatch

Immune Checkpoint Inhibitors Market size is $15,230m in 2019, growing at a CAGR of 25.3% during the forecast period 2020-2025. Immune checkpoint inhibitors are anticancer drugs used in cancer ...

MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer

17h ago, source: YAHOO!

MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal.

Immune Checkpoint Inhibitors Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

3d ago, source: MarketWatch

Some of the key market players are AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company (ARMO BioSciences), Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), F. Hoffmann-La ...

Papers, please: the story behind the 'Checkpoint Barkly' sign

3d ago, source: The Age

An anonymous artist's satirical sign which briefly marked the border into West Footscray is raising money for those locked ...

APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

2d ago, source: PR Newswire

PRNewswire/ -- APEIRON Biologics AG ("APEIRON"), a private biotechnology company specializing in the discovery, development ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.